Menü
Dieses Wertpapier wird aktuell nicht bei uns gehandelt
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Suchergebnisse

LeMaitre Vascular (LMAT) Tops Q1 Earnings Estimates
LeMaitre Vascular (LMAT) Tops Q1 Earnings Estimates

LeMaitre Vascular (LMAT) came out with quarterly earnings of $0.68 per share, beating the Zacks Consensus Estimate of $0.66 per share. This compares to earnings of $0.48 per share a year ago. These

LeMaitre (LMAT) Upgraded to Buy: Here's Why
LeMaitre (LMAT) Upgraded to Buy: Here's Why

LeMaitre Vascular (LMAT) appears an attractive pick, as it has been recently upgraded to a Zacks Rank #2 (Buy). This rating change essentially reflects an upward trend in earnings estimates -- one

3 Reasons Growth Investors Will Love LeMaitre (LMAT)
3 Reasons Growth Investors Will Love LeMaitre (LMAT)

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a great growth